EMA Application withdrawn: Cinainu (dry aqueous extract of paullinia cupana seed;dry hydroethanolic extract of theobroma cacao seed;liquid ethanolic extract 30 per cent (W/W) of Allium cepa fresh bulb and Citrus limon fresh fruit) — Legacy Healthcare (France) S.A.S.

View source ↗

Summary

The European Medicines Agency has withdrawn the marketing authorization application for Cinainu for alopecia areata.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• Cinainu

Snippet

Status: Application withdrawn. Therapeutic area: Alopecia Areata. MAH: Legacy Healthcare (France) S.A.S.. Decision date: 14/11/2024